Neurodegenerative and neuropsychiatric diseases represent a major global and growing public health threat. Thus, there is an urgent, unmet need for drug therapies that will prolong and will maintain/improve quality of life. The continued failure to discover new medicines reflects bottlenecks at: (i) pivotal stages of drug development, and (ii) new, interdisciplinary approaches in neuroscience discovery.

We are planning to create a new institute in the area of translational neuroscience. This institute, Centre for High Impact Neuroscience and  Translational Applications or CHINTA to be based in TCG CREST, will innovate and deliver an integrated approach to solving the above mentioned, difficult challenges. Key to its success will be a network of experts/partnerships distributed across leading international institutions.